SCHEMBL6134698

SCHEMBL6134698

CCOC(=O)c1ccc(N2CCN(C3CCC4(CC3)OCC(C)(C)CO4)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
MAPK1 P28482 2/20 0.41
TSHR P16473 1/20 0.41
HPGD P15428 2/20 0.40
HTT P42858 2/20 0.40
HSP90AA1 P07900 2/20 0.39
FDFT1 P37268 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134434 0.91 ALDH1A1 (0.49) ALDH1A1POLBMEN1KMT2AMAPT
SCHEMBL7318438 0.88 ALDH1A1 (0.53) ALDH1A1POLBMEN1KMT2AMAPT
SCHEMBL6135040 0.84 SMN1; SMN2 (0.43) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL6135046 0.83 KMT2A (0.46) ALDH1A1MEN1KMT2AMAPTITGB3
SCHEMBL63474 0.83 ALDH1A1 (0.59) ALDH1A1POLBMEN1KMT2AMAPT
SCHEMBL6135234 0.81 ALDH1A1 (0.55) ALDH1A1POLBMEN1KMT2AMAPT
SCHEMBL6135228 0.81 ALDH1A1 (0.67) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL63892 0.81 ALDH1A1 (0.63) ALDH1A1POLBMEN1KMT2AMAPT
SCHEMBL6134915 0.80 ALDH1A1 (0.65) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL6135117 0.80 HRH3 (0.42) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 ALDH1A1 3841/4885POLB 1754/4885MEN1 880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.